BUSTI, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 1.980
EU - Europa 1.619
AS - Asia 862
AF - Africa 17
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.492
Nazione #
US - Stati Uniti d'America 1.974
GB - Regno Unito 515
CN - Cina 497
SG - Singapore 238
SE - Svezia 216
RU - Federazione Russa 168
IE - Irlanda 157
FR - Francia 149
IT - Italia 120
DE - Germania 111
FI - Finlandia 98
UA - Ucraina 28
JP - Giappone 24
BE - Belgio 21
VN - Vietnam 21
KR - Corea 20
HK - Hong Kong 14
ID - Indonesia 11
IR - Iran 10
TG - Togo 10
AU - Australia 6
CZ - Repubblica Ceca 6
IN - India 6
PK - Pakistan 6
CA - Canada 5
GR - Grecia 5
EG - Egitto 4
ES - Italia 4
IQ - Iraq 4
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
NL - Olanda 3
TR - Turchia 3
AR - Argentina 2
AT - Austria 2
CL - Cile 2
KG - Kirghizistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IL - Israele 1
IM - Isola di Man 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 4.492
Città #
Southend 463
Chandler 416
Jacksonville 226
Singapore 201
Ann Arbor 164
Dublin 155
Ashburn 147
Woodbridge 130
Beijing 94
New York 90
Wilmington 66
Houston 64
Lawrence 59
Princeton 59
Jinan 42
Boardman 40
Nanjing 40
Helsinki 39
Verona 35
Shenyang 26
Tokyo 23
Lancaster 20
Redmond 20
Brussels 19
Haikou 18
Sindelfingen 18
Hebei 17
Zhengzhou 17
Falls Church 16
Munich 16
Ningbo 16
Seoul 16
Nanchang 15
Tianjin 14
Seattle 13
Changsha 12
Guangzhou 11
Taizhou 11
Lomé 10
Milan 10
Redwood City 10
Santa Clara 10
Taiyuan 10
Jiaxing 9
Fuzhou 8
Hong Kong 8
Norwalk 8
Jakarta 7
Lanzhou 7
Los Angeles 7
Tehran 7
Fairfield 6
Hangzhou 6
San Francisco 6
Alexandria 5
Dong Ket 5
Nettuno 5
Brno 4
Cagliari 4
Chions 4
Dallas 4
Düsseldorf 4
Seongbuk-gu 4
Toronto 4
Washington 4
Athens 3
Bangalore 3
Cerea 3
Kent 3
Kirkuk 3
Madrid 3
Mehlingen 3
Moscow 3
Rome 3
San Mateo 3
Zurich 3
Bandung 2
Berlin 2
Bishkek 2
Cairo 2
Canberra 2
Central 2
Chicago 2
Corridonia 2
Dearborn 2
Dongguan 2
Frankfurt am Main 2
Gunzenhausen 2
Kish 2
Kochi 2
Lappeenranta 2
London 2
Mestre 2
Multan 2
Randolph 2
San Diego 2
San Martino Buon Albergo 2
Surabaya 2
Taranto 2
Waanrode 2
Totale 3.105
Nome #
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 126
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 125
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 117
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 110
A challenging case of abdominal pain associated to Helicobacter pylori infection 109
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 107
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 105
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 103
Identification of new BMP6 pro-peptide mutations in patients with iron overload 103
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 102
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 101
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 101
Paraoxonase-1 status in patients with hereditary hemochromatosis 101
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 98
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 96
Altered paraoxonase expression in patients with genetic haemochromatosis. 95
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 94
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 93
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 93
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 92
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 90
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 89
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 87
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 86
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 82
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 82
Reduced serum hepcidin levels in patients with chronic hepatitis C 77
COBALAMIN DEFICIENCY IN THE ELDERLY 77
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 73
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 73
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 71
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 70
Modern iron replacement therapy: clinical and pathophysiological insights 65
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 65
Paraoxonase-1 status in patients with hereditary hemochromatosis. 64
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 61
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 60
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 59
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 59
Iron deficiency in the elderly population, revisited in the hepcidin era. 57
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 56
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 55
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 55
Iron replacement in inflammatory bowel disease: an evolving scenario 54
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 53
Hyperferritinemia and diagnosis of type 1 Gaucher disease 52
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 52
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 47
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 47
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 47
Impact of natural Neuromedin-B receptor variants on iron metabolism 46
Treatment options for anemia in the elderly 45
Iron metabolism in infections: Focus on COVID-19 45
ERFE regulation in sickle cell disease: complex but promising 43
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 42
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 38
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 36
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 35
Hemochromatosis classification: update and recommendations by the BIOIRON Society 26
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 19
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 18
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 17
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 16
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 15
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 15
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 13
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 13
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 11
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 10
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 9
Recent Advancement of Hematology: Know, How to Do, Let Know 8
Manipulating hepcidin in polycythemia vera 8
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 7
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 2
Totale 4.573
Categoria #
all - tutte 16.816
article - articoli 12.233
book - libri 0
conference - conferenze 4.369
curatela - curatele 0
other - altro 214
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020290 0 0 0 0 62 36 36 21 31 49 18 37
2020/2021434 19 76 22 49 78 52 18 17 10 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/2025574 82 111 65 255 61 0 0 0 0 0 0 0
Totale 4.573